The cytosolic tryparedoxin peroxidase from Trypanosoma cruzi induces a pro-inflammatory Th1 immune response in a peroxidatic cysteine-dependent manner.


Journal

Immunology
ISSN: 1365-2567
Titre abrégé: Immunology
Pays: England
ID NLM: 0374672

Informations de publication

Date de publication:
05 2021
Historique:
revised: 25 11 2020
received: 17 09 2020
accepted: 19 12 2020
pubmed: 8 1 2021
medline: 5 10 2021
entrez: 7 1 2021
Statut: ppublish

Résumé

Trypanosoma cruzi cytosolic tryparedoxin peroxidase (c-TXNPx) is a 2-Cys peroxiredoxin (Prx) with an important role in detoxifying host cell oxidative molecules during parasite infection. c-TXNPx is a virulence factor, as its overexpression enhances parasite infectivity and resistance to exogenous oxidation. As Prxs from other organisms possess immunomodulatory properties, we studied the effects of c-TXNPx in the immune response and analysed whether the presence of the peroxidatic cysteine is necessary to mediate these properties. To this end, we used a recombinant c-TXNPx and a mutant version (c-TXNPxC52S) lacking the peroxidatic cysteine. We first analysed the oligomerization profile, oxidation state and peroxidase activity of both proteins by gel filtration, Western blot and enzymatic assay, respectively. To investigate their immunological properties, we analysed the phenotype and functional activity of macrophage and dendritic cells and the T-cell response by flow cytometry after injection into mice. Our results show that c-TXNPx, but not c-TXNPxC52S, induces the recruitment of IL-12/23p40-producing innate antigen-presenting cells and promotes a strong specific Th1 immune response. Finally, we studied the cellular and humoral immune response developed in the context of parasite natural infection and found that only wild-type c-TXNPx induces proliferation and high levels of IFN-γ secretion in PBMC from chronic patients without demonstrable cardiac manifestations. In conclusion, we demonstrate that c-TXNPx possesses pro-inflammatory properties that depend on the presence of peroxidatic cysteine that is essential for peroxidase activity and quaternary structure of the protein and could contribute to rational design of immune-based strategies against Chagas disease.

Identifiants

pubmed: 33410127
doi: 10.1111/imm.13302
pmc: PMC8044337
doi:

Substances chimiques

Cytokines 0
Inflammation Mediators 0
Protozoan Proteins 0
Peroxidases EC 1.11.1.-
tryparedoxin peroxidase EC 1.11.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

46-59

Informations de copyright

© 2021 John Wiley & Sons Ltd.

Références

Cell. 2004 May 28;117(5):625-35
pubmed: 15163410
Antioxid Redox Signal. 2008 Sep;10(9):1593-606
pubmed: 18498224
PLoS Negl Trop Dis. 2018 Mar 30;12(3):e0006384
pubmed: 29601585
Immunity. 2019 Aug 20;51(2):337-350.e7
pubmed: 31375460
Biochem Biophys Res Commun. 2006 Jun 23;345(1):118-23
pubmed: 16677601
Nat Chem Biol. 2015 Jan;11(1):64-70
pubmed: 25402766
Vaccine. 2016 Jun 14;34(28):3243-51
pubmed: 27177947
Acta Trop. 2010 Jul-Aug;115(1-2):14-21
pubmed: 19932071
Biochim Biophys Acta Gen Subj. 2019 Oct;1863(10):1583-1594
pubmed: 31265897
Curr Opin Immunol. 2007 Aug;19(4):430-4
pubmed: 17651955
Nat Med. 2012 Jun;18(6):911-7
pubmed: 22610280
Exp Parasitol. 2013 Mar;133(3):287-93
pubmed: 23266485
Curr Opin Immunol. 2010 Oct;22(5):552-9
pubmed: 20869863
FASEB J. 2008 Nov;22(11):4022-32
pubmed: 18708590
Vet Res. 2011 Jun 27;42:80
pubmed: 21707997
Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):E616-24
pubmed: 25646478
Science. 2003 Apr 25;300(5619):650-3
pubmed: 12714747
Rheumatology (Oxford). 2006 Sep;45(9):1101-9
pubmed: 16567360
Trends Biochem Sci. 2015 Aug;40(8):435-45
pubmed: 26067716
Methods. 2006 Sep;40(1):1-9
pubmed: 16997708
Infect Immun. 2005 Jan;73(1):166-73
pubmed: 15618151
Lancet Infect Dis. 2018 Apr;18(4):363-365
pubmed: 29352705
J Biol Chem. 2015 Mar 27;290(13):8582-90
pubmed: 25666622
Arch Biochem Biophys. 2011 Mar 15;507(2):287-95
pubmed: 21167808
Eur J Immunol. 2008 May;38(5):1341-50
pubmed: 18398934
J Biol Chem. 2002 Oct 11;277(41):38029-36
pubmed: 12161445
Hum Vaccin Immunother. 2017 Mar 4;13(3):621-633
pubmed: 27737611
Lancet. 2018 Jun 2;391(10136):2209-2210
pubmed: 29893217
Cytometry A. 2019 Dec;95(12):1226-1230
pubmed: 31424632
Mol Cells. 2016 Jan;39(1):60-4
pubmed: 26813661
J Exp Med. 2000 Nov 6;192(9):1213-22
pubmed: 11067871
BMC Microbiol. 2010 Jan 26;10:20
pubmed: 20102621
PLoS Negl Trop Dis. 2017 Jan 23;11(1):e0005307
pubmed: 28114324
Biom J. 2008 Jun;50(3):346-63
pubmed: 18481363
Mol Cell Proteomics. 2009 Aug;8(8):1891-907
pubmed: 19443417
PLoS One. 2016 Oct 7;11(10):e0164586
pubmed: 27716839
J Proteome Res. 2013 Feb 1;12(2):883-97
pubmed: 23214914
FEBS Lett. 2009 Jun 18;583(12):1809-16
pubmed: 19464293
Nat Rev Cardiol. 2012 Oct;9(10):576-89
pubmed: 22847166
Immunology. 2018 Nov;155(3):367-378
pubmed: 29972690
PLoS One. 2017 Oct 3;12(10):e0185504
pubmed: 28972996
Biomed Res Int. 2014;2014:439501
pubmed: 24812617
J Immunol. 2010 Jan 15;184(2):1022-30
pubmed: 20018613
Mol Biochem Parasitol. 2016 Mar-Apr;206(1-2):2-12
pubmed: 27002228
Redox Biol. 2019 Jun;24:101203
pubmed: 31026770
Antioxid Redox Signal. 2018 Mar 1;28(7):574-590
pubmed: 28762774
Biochem J. 2008 Mar 1;410(2):359-68
pubmed: 17973627
Nat Chem Biol. 2018 Feb;14(2):148-155
pubmed: 29251718
Parasite Immunol. 2010 May;32(5):305-13
pubmed: 20500659
Cytokine. 2015 May;73(1):190-5
pubmed: 25771243
J Clin Biochem Nutr. 2012 Mar;50(2):91-105
pubmed: 22448089
Gene. 2008 Jan 31;408(1-2):45-50
pubmed: 18022330
PLoS One. 2017 Apr 27;12(4):e0176324
pubmed: 28448521
Infect Immun. 2016 May 24;84(6):1842-1856
pubmed: 27068090
Front Immunol. 2018 Aug 24;9:1929
pubmed: 30197647
J Pharm Sci. 2008 Jun;97(6):2041-4
pubmed: 17847072

Auteurs

Lucía López (L)

Laboratorio de Inmunomodulación y Desarrollo de Vacunas, Departamento de Inmunobiología, Facultad de Medicina, Universidad de La República, Montevideo, Uruguay.
Unidad de Biología Molecular, Institut Pasteur Montevideo, Montevideo, Uruguay.

María Laura Chiribao (ML)

Unidad de Biología Molecular, Institut Pasteur Montevideo, Montevideo, Uruguay.
Departamento de Bioquímica, Facultad de Medicina, Universidad de La República, Montevideo, Uruguay.

Magalí C Girard (MC)

Laboratorio de Inmunología de las Infecciones por Tripanosomátidos, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular (INGEBI-CONICET), Buenos Aires, Argentina.

Karina A Gómez (KA)

Laboratorio de Inmunología de las Infecciones por Tripanosomátidos, Instituto de Investigaciones en Ingeniería Genética y Biología Molecular (INGEBI-CONICET), Buenos Aires, Argentina.

Paula Carasi (P)

Laboratorio de Inmunomodulación y Desarrollo de Vacunas, Departamento de Inmunobiología, Facultad de Medicina, Universidad de La República, Montevideo, Uruguay.

Marisa Fernandez (M)

Instituto Nacional de Parasitología 'Doctor Mario Fatala Chabén', Buenos Aires, Argentina.

Yolanda Hernandez (Y)

Instituto Nacional de Parasitología 'Doctor Mario Fatala Chabén', Buenos Aires, Argentina.

Carlos Robello (C)

Unidad de Biología Molecular, Institut Pasteur Montevideo, Montevideo, Uruguay.
Departamento de Bioquímica, Facultad de Medicina, Universidad de La República, Montevideo, Uruguay.

Teresa Freire (T)

Laboratorio de Inmunomodulación y Desarrollo de Vacunas, Departamento de Inmunobiología, Facultad de Medicina, Universidad de La República, Montevideo, Uruguay.

María Dolores Piñeyro (MD)

Unidad de Biología Molecular, Institut Pasteur Montevideo, Montevideo, Uruguay.
Departamento de Bioquímica, Facultad de Medicina, Universidad de La República, Montevideo, Uruguay.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH